Select a dose to see the cheapest documented option that covers it. Providers with verified same-price-across-dose terms are included automatically at every applicable dose; there is no separate flat-price selection. Flat-rate and variable dose-tier providers compete together, with verified required fees included. Comparable monthly, 28-day, 30-day, and four-week injection supplies retain their actual billing labels; no monthly equivalent is invented. Unmatched offers remain visible but unranked. Dose tiers are catalog information, not dosing advice.
subcutaneous injection; 5 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.; 100mcg SQ daily for 4 Weeks ($295); 150mcg SQ daily for 4 Weeks ($295); 200mcg SQ daily for 4 Weeks ($295); 250mcg SQ daily for 4 Weeks ($295); 300mcg SQ daily for 4 Weeks ($295)
Current Recess Rx managed-medication identity; exact route, strength, concentration, package, prescribed duration, pharmacy, and medication amount are not public.
subcutaneous injection; 5 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.; 100mcg SQ daily for 4 Weeks ($295); 150mcg SQ daily for 4 Weeks ($295); 200mcg SQ daily for 4 Weeks ($295); 250mcg SQ daily for 4 Weeks ($295); 300mcg SQ daily for 4 Weeks ($295)
Current Recess Rx managed-medication identity; exact route, strength, concentration, package, prescribed duration, pharmacy, and medication amount are not public.
Daily injectable LL-37/cathelicidin; dose depends on the provider-directed use case.
Video or phone visit
Regulatory context under reviewSources checked Aug 16, 2026
Regulatory and pricing context
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion. Context source
Displayed prices and dose options are provider-stated snapshots. They may vary by dose, formulation, shipping, state, eligibility, insurance, commitment length, and required subscription. “Not listed” means the reviewed public source did not provide a value.
Information only; not medical advice, a safety evaluation, or a provider endorsement.
Research-use-only suppliers are separate. Their catalog prices never enter the prescription-provider comparison above.